Literature DB >> 7530908

Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells.

M E Egan1, E M Schwiebert, W B Guggino.   

Abstract

When nonepithelial cell types expressing the delta F508-cystic fibrosis transmembrane conductance regulator (CFTR) mutation are grown at reduced temperatures, the mutant protein can be properly processed. The effect of low temperatures on Cl- channel activity in airway epithelial cells that endogenously express the delta F508-CFTR mutation has not been investigated. Therefore, we examined the effect of incubation temperature on both CFTR and outwardly rectifying Cl- channel (ORCC) activity in normal, in cystic fibrosis (CF)-affected, and in wild-type CFTR-complemented CF airway epithelia with use of a combination of inside-out and whole cell patch-clamp recording, 36Cl- efflux assays, and immunocytochemistry. We report that incubation of CF-affected airway epithelial cells at 25-27 degrees C is associated with the appearance of a protein kinase A-stimulated CFTR-like Cl- conductance. In addition to the appearance of CFTR Cl- channel activity, there is, however, a decrease in the number of active ORCC when cells are grown at 25-27 degrees C, suggesting that the decrease in incubation temperature may be associated with multiple alterations in ion channel expression and/or regulation in airway epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530908     DOI: 10.1152/ajpcell.1995.268.1.C243

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Novel pharmacologic therapies for cystic fibrosis.

Authors:  P L Zeitlin
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 2.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

Review 3.  delta F508 in cystic fibrosis: willing but not able.

Authors:  K W Southern
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 4.  Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.

Authors:  Ronald C Rubenstein
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

5.  Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia.

Authors:  Eric S Schiffhauer; Neeraj Vij; Olga Kovbasnjuk; Po Wei Kang; Doug Walker; Seakwoo Lee; Pamela L Zeitlin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

6.  In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.

Authors:  R C Rubenstein; M E Egan; P L Zeitlin
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 7.  Gene therapy for cystic fibrosis.

Authors:  Christian Mueller; Terence R Flotte
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

8.  Rational Coupled Dynamics Network Manipulation Rescues Disease-Relevant Mutant Cystic Fibrosis Transmembrane Conductance Regulator.

Authors:  Elizabeth A Proctor; Pradeep Kota; Andrei A Aleksandrov; Lihua He; John R Riordan; Nikolay V Dokholyan
Journal:  Chem Sci       Date:  2015-02       Impact factor: 9.825

9.  CFTR Deletion in Mouse Testis Induces VDAC1 Mediated Inflammatory Pathway Critical for Spermatogenesis.

Authors:  Chen Yan; Qin Lang; Liao Huijuan; Xie Jiang; Yang Ming; Sun Huaqin; Xu Wenming
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

Review 10.  Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.

Authors:  Anjali Y Bhagirath; Yanqi Li; Deepti Somayajula; Maryam Dadashi; Sara Badr; Kangmin Duan
Journal:  BMC Pulm Med       Date:  2016-12-05       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.